Dystroglycan receptor is involved in integrin activation in intestinal epithelia

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 290, Issue 6, 2006, Pages

  Driss, Adel ^a   Charrier, Laetitia ^a   Yan, Yutao ^a   Nduati, Vivienne ^a   Sitaraman, Shanthi ^a   Merlin, Didier ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

1 integrin; Caco 2 BBE; Electric cell substrate impedance sensing; Laminin

Indexed keywords

BETA1 INTEGRIN; DYSTROGLYCAN; INTEGRIN; LAMININ 1; MEROSIN; UTROPHIN;

ANIMAL CELL; ARTICLE; CACAO; CELL STRAIN CACO 2; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANTIGENS, CD29; CACO-2 CELLS; DYSTROGLYCANS; DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX; HUMANS; INTESTINAL MUCOSA; LAMININ;

EID: 33646866969     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00378.2005     Document Type: Article

References (57)

1. Beaulieu JF. Integrins and human intestinal cell functions. Front Biosci 4: D310-D321, 1999.
2. Blake DJ, Schofield JN, Zuellig RA, Gorecki DC, Phelps SR, Barnard EA, Edwards YH, and Davies KE. G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain. Proc Natl Acad Sci USA 92: 3697-3701, 1995.
3. Brown RH Jr and Hoffman EP. Molecular biology of Duchenne muscular dystrophy. Trends Neurosci 11: 480-483, 1988.
4. Brown SC, Fassati A, Popplewell L, Page AM, Henry MD, Campbell KP, and Dickson G. Dystrophic phenotype induced in vitro by antibody blockade of muscle alpha-dystroglycan-laminin interaction. J Cell Sci 112: 209-216, 1999.
5. Buyse M, Sitaraman SV, Liu X, Bado A, and Merlin D. Luminal leptin enhances CD147/MCT-1-mediated uptake of butyrate in the human intestinal cell line Caco-2-BBE. J Biol Chem 277: 28182-28190, 2002.
6. Byers T, Lidov HG, and Kunkel LM. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 4: 87-93, 1993.
7. Campbell KP. Three muscular dystrophies: loss of cytoskeleton- extracellular matrix linkage. Cell 80: 675-679, 1995.
8. Chantret I, Barbat A, Dussaulx E, Brattain MG, and Zweibaum A. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res 48: 1936-1942, 1988.
9. Chantret I, Trugnan G, Dussaulx E, Zweibaum A, and Rousset M. Monensin inhibits the expression of sucrase-isomaltase in Caco-2 cells at the mRNA level. FEBS Lett 235: 125-128, 1988.
10. Colognato H and Yurchenco PD. Form and function: the laminin family of heterotrimers. Dev Dyn 218: 213-234, 2000.
11. Durbeej M, Larsson E, Ibraghimov-Beskrovnaya O, Roberds SL, Campbell KP, and Ekblom P. Non-muscle alpha-dystroglycan is involved in epithelial development. J Cell Biol 130: 79-91, 1995.
12. Eilers U, Klumperman J, and Hauri HP. Nocodazole, a microtubule-active drug, interferes with apical protein delivery in cultured intestinal epithelial cells (Caco-2). J Cell Biol 108: 13-22, 1989.
13. Ervasti JM and Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell 66: 1121-1131, 1991.
14. Ervasti JM and Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122: 809-823, 1993.
15. Ervasti JM, Ohlendeick K, Kahl SD, Gaver MG, and Campbell KP. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345: 315-319, 1990.
16. Fabbrizio E, Latouche J, Rivier F, Hugon G, and Mornet D. Reevaluation of the distributions of dystrophin and utrophin in sciatic nerve. Biochem J 312: 309-314, 1995.
17. Feener CA, Koenig M, and Kunkel LM. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature 338: 509-511, 1989.
18. Gee SH, Blacher RW, Douville PJ, Provost PR, Yurchenco PD, and Carbonetto S. Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J Biol Chem 268: 14972-14980, 1993.
19. Gesemann M, Brancaccio A, Schumacher B, and Ruegg MA. Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. J Biol Chem 273: 600-605, 1998.
20. Giaever I and Keese CR. A morphological biosensor for mammalian cells. Nature 366: 591-592, 1993.
21. Giaever I and Keese CR. Monitoring fibroblast behavior in tissue culture with an applied electric field. Proc Natl Acad Sci USA 81: 3761-3764, 1984.
22. Henry MD and Campbell KP. A role for dystroglycan in basement membrane assembly. Cell 95: 859-870, 1998.
23. Hoffman EP, Hudecki MS, Rosenberg PA, Pollina CM, and Kunkel LM. Cell and fiber-type distribution of dystrophin. Neuron 1: 411-420, 1988.
24. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25, 1992.
25. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, and Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696-702, 1992.
26. Ibraghimov-Beskrovnaya O, Milatovich A, Ozcelik T, Yang B, Koepknik K, Franke U, and Campbell KP. Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol Genet 2: 1651-1657, 1993.
27. Ishikawa-Sakurai M, Yoshida M, Imamura M, Davies KE, and Ozawa E. ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to beta-dystroglycan. Hum Mol Genet 13: 693-702, 2004.
28. James M, Nguyen TM, Wise CJ, Jones GE, and Morris GE. Utrophin-dystroglycan complex in membranes of adherent cultured cells. Cell Motil Cytoskeleton 33: 163-174, 1996.
29. Jung D, Yang B, Meyer J, Chamberlain JS, and Campbell KP. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem 270: 27305-27310, 1995.
30. Kachinsky AM, Froehner SC, and Milgram SL. A PDZ-containing scaffold related to the dystrophin complex at the basolateral membrane of epithelial cells. J Cell Biol 145: 391-402, 1999.
31. Keese CR, Wegener JR, Walker S, and Giaever I. Electrical wound-healing assay for cells in vitro. Proc Natl Acad Sci USA 101: 1554-1559, 2004.
32. Kikkawa Y, Yu H, Genersch E, Sanzen N, Sekiguchi K, Fassler R, Campbell KP, Talts JF, and Ekblom P. Laminin isoforms differentially regulate adhesion, spreading, proliferation, and ERK activation of beta1 integrin-null cells. Exp Cell Res 300: 94-108, 2004.
33. Korhonen M, Ylanne J, Laitinen L, and Virtanen I. The alpha 1-alpha 6 subunits of integrins are characteristically expressed in distinct segments of developing and adult human nephron. J Cell Biol 111: 1245-1254, 1990.
34. Le Bivic A, Quaroni A, Nichols B, and Rodriguez-Boulan E. Biogenetic pathways of plasma membrane proteins in Caco-2, a human intestinal epithelial cell line. J Cell Biol 111: 1351-1361, 1990.
35. Losasso C, Di Tommaso F, Sgambato A, Ardito R, Cittadini A, Giardina B, Petrucci TC, and Brancaccio A. Anomalous dystroglycan in carcinoma cell lines. FEBS Lett 484: 194-198, 2000.
36. Love DR, Hill DF, Dickson G, Spurr NK, Byth BC, Marsden RF, Walsh FS, Edwards YH, and Davies KE. An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 339: 55-58, 1989.
37. Mooseker MS. Organization, chemistry, and assembly of the cytoskeletal apparatus of the intestinal brush border. Annu Rev Cell Biol 1: 209-241, 1985.
38. Muschler J, Levy D, Boudreau R, Henry M, Campbell K, and Bissell MJ. A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. Cancer Res 62: 7102-7109, 2002.
39. Nguyen TM, Ellis JM, Love DR, Davies KE, Gatter KC, Dickson G, and Morris GE. Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J Cell Biol 115: 1695-700, 1991.
40. Nguyen TM, Helliwell TR, Simmons C, Winder SJ, Kendrick-Jones J, Davies KE, and Morris GE. Full-length and short forms of utrophin, the dystrophin-related protein. FEBS Lett 358: 262-266, 1995.
41. Osses N and Brandan E. ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression. Am J Physiol Cell Physiol 282: C383-C394, 2002.
42. Pall EA, Bolton KM, and Ervasti JM. Differential heparin inhibition of skeletal muscle alpha-dystroglycan binding to laminins. J Biol Chem 271: 3817-3821, 1996.
43. Peng HB, Ali AA, Daggett DF, Rauvala H, Hassel JR, and Smalheiser NR. The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhes Commun 5: 475-489, 1998.
44. Schofield JN, Blake DJ, Simmons C, Morris GE, Tinsley JM, Davies KE, and Edwards YH. Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines. Hum Mol Genet 8: 1309-1316, 1994.
45. Sorokin L, Sonnenberg A, Aumailley M, Timpl R, and Ekblom P. Recognition of the laminin E8 cell-binding site by an integrin possessing the alpha 6 subunit is essential for epithelial polarization in developing kidney tubules. J Cell Biol 111: 1265-1273, 1990.
46. Stieger B, Matter K, Baur B, Bucher K, Hochli M, and Hauri HP. Dissection of the asynchronous transport of intestinal microvillar hydrolases to the cell surface. J Cell Biol 106: 1853-1861, 1988.
47. Sunada Y, Bernier SM, Kozak CA, Yamada Y, and Campbell KP. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem 269: 13729-13732, 1994.
48. Suzuki A, Yoshida M, Hayashi K, Mizuno Y, Hagiwara Y, and Ozawa E. Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur J Biochem 220: 283-292, 1994.
49. Talts JF, Zeynep A, Goring W, Brancaccio A, and Timpl R. Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins. EMBO J 18: 863-870, 1999.
50. Teller IC and Beaulieu JF. Interactions between laminin and epithelial cells in intestinal health and disease. Expert Rev Mol Med 2001: 1-18, 2001.
51. Wegener J, Keese CR, and Giaever I. Electric cell-substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces. Exp Cell Res 259: 158-166, 2000.
52. Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, Sunada Y, Ibraghimov-Beskrovnaya O, and Campbell KP. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet 6: 831-841, 1997.
53. Wilson J, Putt W, Jimenez C, and Edwards YH. Up71 and up140, two novel transcripts of utrophin that are homologues of short forms of dystrophin. Hum Mol Genet 8: 1271-1278, 1999.
54. Winder SJ. The complexities of dystroglycan. Trends Biochem Sci 26: 118-124, 2001.
55. Xiao C, Lachance B, Sunahara G, and Luong JH. An in-depth analysis of electric cell-substrate impedance sensing to study the attachment and spreading of mammalian cells. Anal Chem 74: 1333-1339, 2002.
56. Yoshida M, Suzuki A, Yammamoto H, Noguchi S, Mizuno Y, and Ozawa E. Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside. Eur J Biochem 222: 1055-1061, 1994.
57. Zuellig RA, Bornhauser BC, Knuesel I, Heller F, Fritschy JM, and Schaub MC. Identification and characterization of transcript and protein of a new short N-terminal utrophin isoform. J Cell Biochem 77: 418-431, 2000.